• Urgent need for rapid, simple to use, point of care diagnostics

  • Detection of breath-based disease biomarkers is a viable approach using microGC

  • Does not require development of disease-specific reagents (primers, antibodies, etc.), but instead relies on pattern of VOCs in patient breath to provide immediate assessment

  • VOC biomarkers have been investigated for multiple diseases, including asthma, COPD, CF, pneumonia and TB

  • Investigating detection of COVID-19 using microGC technology